Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2026-02-20 @ 4:49 PM
Study NCT ID:
NCT03019003
Status:
COMPLETED
Last Update Posted:
2025-09-16
First Post:
2017-01-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients
Sponsor:
Massachusetts General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
16-425
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None